MD285Z - Метод прогнозирования развития пузырного заноса - Google Patents
Метод прогнозирования развития пузырного заноса Download PDFInfo
- Publication number
- MD285Z MD285Z MDS20100091A MDS20100091A MD285Z MD 285 Z MD285 Z MD 285Z MD S20100091 A MDS20100091 A MD S20100091A MD S20100091 A MDS20100091 A MD S20100091A MD 285 Z MD285 Z MD 285Z
- Authority
- MD
- Moldova
- Prior art keywords
- result
- factors
- risk
- pathologies
- hydatidiform mole
- Prior art date
Links
- 208000006937 Hydatidiform mole Diseases 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000011161 development Methods 0.000 title claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 15
- 206010004272 Benign hydatidiform mole Diseases 0.000 claims description 37
- 201000007116 gestational trophoblastic neoplasm Diseases 0.000 claims description 37
- 230000007170 pathology Effects 0.000 claims description 29
- 230000027758 ovulation cycle Effects 0.000 claims description 8
- 239000003433 contraceptive agent Substances 0.000 claims description 7
- 230000002254 contraceptive effect Effects 0.000 claims description 7
- 208000009889 Herpes Simplex Diseases 0.000 claims description 6
- 208000037093 Menstruation Disturbances Diseases 0.000 claims description 6
- 241000701022 Cytomegalovirus Species 0.000 claims description 5
- 206010067162 Asthenospermia Diseases 0.000 claims description 4
- 206010000210 abortion Diseases 0.000 claims description 4
- 231100000176 abortion Toxicity 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 230000000391 smoking effect Effects 0.000 claims description 4
- 208000000995 spontaneous abortion Diseases 0.000 claims description 4
- 241000606161 Chlamydia Species 0.000 claims description 3
- 206010021033 Hypomenorrhoea Diseases 0.000 claims description 3
- 208000035175 Oligomenorrhea Diseases 0.000 claims description 3
- 206010030295 Oligomenorrhoea Diseases 0.000 claims description 3
- 206010036086 Polymenorrhoea Diseases 0.000 claims description 3
- 208000002312 Teratozoospermia Diseases 0.000 claims description 3
- 201000005485 Toxoplasmosis Diseases 0.000 claims description 3
- 206010003883 azoospermia Diseases 0.000 claims description 3
- 230000003054 hormonal effect Effects 0.000 claims description 3
- 208000022168 hypermenorrhea Diseases 0.000 claims description 3
- 208000007106 menorrhagia Diseases 0.000 claims description 3
- 208000008634 oligospermia Diseases 0.000 claims description 3
- 230000036616 oligospermia Effects 0.000 claims description 3
- 231100000528 oligospermia Toxicity 0.000 claims description 3
- 210000001685 thyroid gland Anatomy 0.000 claims description 3
- 206010000234 Abortion spontaneous Diseases 0.000 claims description 2
- 230000007774 longterm Effects 0.000 claims description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 abstract description 9
- 208000006332 Choriocarcinoma Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 2
- 208000019255 Menstrual disease Diseases 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000036210 malignancy Effects 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 4
- 230000001568 sexual effect Effects 0.000 description 4
- 235000019504 cigarettes Nutrition 0.000 description 3
- 230000005741 malignant process Effects 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 208000005125 Invasive Hydatidiform Mole Diseases 0.000 description 2
- 208000031271 Unwanted pregnancy Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 230000009247 menarche Effects 0.000 description 2
- 230000000771 oncological effect Effects 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 241000722343 Human papillomavirus types Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000035663 Invasive mole Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000003884 gestational trophoblastic disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007778 menstrual function Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001573 trophoblastic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Landscapes
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Изобретение относится к медицине, в частности к гинекологии и может быть использовано для прогнозирования развития пузырного заноса и хориокарциномыСогласно изобретению, метод состоит в том, что выявляют следующие факторы: среда проживания, социальные категории, наличие вредных привычек, нарушение менструального цикла, метод контрацепции, болезни передающиеся половым путем, анамнез, наличие сопутствующих болезней, результат спермограмы партнера, выявленным факторам присваивают определенные значения, затем значения, присвоенные выявленным факторам суммируют и разделяют на количество выявленных факторов и в случае, если полученный результат составляет 1,0…2,0 прогнозируют повышенный риск развития пузырного заноса, если результат составляет 1,4…2,7 прогнозируют средний риск развития пузырного заноса, а если результат составляет 2,8…3,2 прогнозируют минимальный риск развития пузырного заноса.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20100091A MD285Z (ru) | 2010-05-19 | 2010-05-19 | Метод прогнозирования развития пузырного заноса |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20100091A MD285Z (ru) | 2010-05-19 | 2010-05-19 | Метод прогнозирования развития пузырного заноса |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD285Y MD285Y (en) | 2010-10-29 |
| MD285Z true MD285Z (ru) | 2011-05-31 |
Family
ID=45815202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20100091A MD285Z (ru) | 2010-05-19 | 2010-05-19 | Метод прогнозирования развития пузырного заноса |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD285Z (ru) |
-
2010
- 2010-05-19 MD MDS20100091A patent/MD285Z/ru not_active IP Right Cessation
Non-Patent Citations (2)
| Title |
|---|
| Трофобластическая болезнь. Медицинский Центр Артмед, 2002, găsit în internet: <URL: http:// http://www.art-med.ru/articles/list/art203.asp > * |
| Трофобластическая болезнью Медицинский Центр Артмед, 2002. găsit pe 2010.04.20 <URL: http:// http://www.art-med.ru/articles/list/art203.asp > * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD285Y (en) | 2010-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Karaer et al. | Risk factors for ectopic pregnancy: A case‐control study | |
| Gadducci et al. | Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature | |
| Baeten et al. | Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study | |
| Wen et al. | Risk factors for the acquisition of genital warts: are condoms protective? | |
| Firnhaber et al. | Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa | |
| Anderson et al. | The prevalence of abnormal genital findings, vulvovaginitis, enuresis and encopresis in children who present with allegations of sexual abuse | |
| Azevedo et al. | Epidemiology of human papillomavirus on anogenital warts in Portugal–The HERCOLES study | |
| Finger‐Jardim et al. | Herpes simplex virus: prevalence in placental tissue and incidence in neonatal cord blood samples | |
| Marcone et al. | Epidemiology of Chlamydia trachomatis endocervical infection in a previously unscreened population in Rome, Italy, 2000 to 2009 | |
| Ikeako et al. | Pattern and outcome of induced abortion in Abakaliki, Southeast of Nigeria | |
| Burkett et al. | The relationship between contraceptives, sexual practices, and cervical human papillomavirus infection among a college population | |
| Kelly-Weeder et al. | Modifiable risk factors for impaired fertility in women: What nurse practitioners need to know | |
| Altunyurt et al. | A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease | |
| Casillas-Vega et al. | Sexually transmitted pathogens, coinfections and risk factors in patients attending obstetrics and gynecology clinics in Jalisco, Mexico | |
| Pista et al. | Risk factors for human papillomavirus infection among women in Portugal: the CLEOPATRE Portugal Study | |
| Mazanowska1ABCDEF et al. | Prevalence of cervical high-risk human papillomavirus infections in kidney graft recipients | |
| Wang et al. | Risk factors for cervical intraepithelial neoplasia in Taiwan | |
| Damario | General aspects of fertility and infertility | |
| Ganesan et al. | Associated factors with cervical pre-malignant lesions among the married fisher women community at Sadras, Tamil Nadu | |
| Warren et al. | Sexuality and reproductive risk factors for interstitial cystitis/painful bladder syndrome in women | |
| Kalaichelvan et al. | Actinomyces in cervical smears of women using the intrauterine device in Singapore | |
| MD285Z (ru) | Метод прогнозирования развития пузырного заноса | |
| Nyarko et al. | Chlamydia trachomatis prevalence in Ghana-A study at a municipal district in Western Ghana | |
| Clarke et al. | A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica | |
| Pickard et al. | Persistent vaginal bleeding in a patient with a broken Implanon® |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |